Paper reopens debate over drug sampling

As a new research paper spurs debate, the countdown is ticking on a pandemic-era policy change that may affect one of healthcare marketing’s most controversial tactics.

Pharma companies give away billions of dollars worth of free prescription drug samples every year. One study found that, based on the retail value of said products, drug sampling as a marketing channel far eclipses the amounts invested in all others combined.